Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berkeley Heights, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Tonix Pharmaceuticals Holding Corp. has filed 1,514 SEC EDGAR filings since 09 Apr 2008

SEC filing history

Showing 126-150 of 1,000 matching filings.

Per page
25
Current page
6
8-K File 001-36019

CURRENT REPORT

Filing date
29 Apr 2025
Reporting date
29 Apr 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
25 Apr 2025
Reporting date
25 Apr 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
24 Apr 2025
Reporting date
23 Apr 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
09 Apr 2025
Reporting date
09 Apr 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
01 Apr 2025
Reporting date
01 Apr 2025
Next action
Verify source filing
DEF 14A File 001-36019

DEFINITIVE PROXY STATEMENT

Filing date
31 Mar 2025
Reporting date
08 May 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
24 Mar 2025
Reporting date
24 Mar 2025
Next action
Verify source filing
PRE 14A File 001-36019

PRELIMINARY PROXY STATEMENT

Filing date
21 Mar 2025
Reporting date
08 May 2025
Next action
Verify source filing
ARS File 001-36019

ANNUAL REPORT TO SECURITY HOLDERS

Filing date
18 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
18 Mar 2025
Reporting date
18 Mar 2025
Next action
Verify source filing
10-K File 001-36019

ANNUAL REPORT

Filing date
18 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
10 Mar 2025
Reporting date
10 Mar 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
04 Mar 2025
Reporting date
27 Feb 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
04 Mar 2025
Reporting date
03 Mar 2025
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filing date
28 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filing date
28 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filing date
28 Feb 2025
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filing date
28 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - SAENGER

Filing date
27 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - SULLIVAN

Filing date
27 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - LEDERMAN

Filing date
27 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - MORRIS

Filing date
27 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - FOGARTY

Filing date
27 Feb 2025
Reporting date
25 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
21 Feb 2025
Reporting date
20 Feb 2025
Next action
Verify source filing
3

3 filing

Filing date
18 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .